Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. Influence on Metabolic Abnormalities
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Abacavir; Lamivudine; Lamivudine/zidovudine/abacavir; Non-nucleoside reverse transcriptase inhibitors
- Indications HIV infections
- Focus Adverse reactions
Most Recent Events
- 23 Aug 2011 New trial record